Poor Water Solubility of SLU-PP-332 Led to Development of SLU-PP-915 as a Follow-On Compound
The bioavailability problems identified with SLU-PP-332 directly motivated researchers to develop SLU-PP-915 as a successor compound. The explicit goal of SLU-PP-915 was to address the oral bioavailability deficiencies of SLU-PP-332. This suggests SLU-PP-915 may have improved water solubility or formulation characteristics.
SLU-PP-915 Developed Specifically to Address SLU-PP-332 Bioavailability Failure
The poor oral bioavailability of SLU-PP-332 directly motivated the development of a successor compound, SLU-PP-915. The implication is that SLU-PP-915 was engineered with improved solubility or absorption characteristics to overcome the limitations identified with SLU-PP-332. No dosage or clinical outcome data for SLU-PP-915 is provided in this excerpt.
Poor Water Solubility of SLU-PP-332 Led to Development of SLU-PP-915 as a Successor Compound
The bioavailability problems identified with SLU-PP-332 directly motivated researchers to develop SLU-PP-915 as an improved analog. SLU-PP-915 was specifically designed to address the oral bioavailability deficiencies of its predecessor. This suggests an active research effort to create a more clinically viable version of the compound.